Found: 9
Select item for more details and to access through your institution.
Front Cover.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 12, p. C1, doi. 10.1111/dom.15371
- By:
- Publication type:
- Article
Efficacy and safety of the sodium‐glucose co‐transporter‐2 inhibitor empagliflozin in elderly Japanese adults (≥65 years) with type 2 diabetes: A randomized, double‐blind, placebo‐controlled, 52‐week clinical trial (EMPA‐ELDERLY)
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 12, p. 3538, doi. 10.1111/dom.15249
- By:
- Publication type:
- Article
Efficacy and safety of empagliflozin as add‐on to insulin in Japanese patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 3, p. 417, doi. 10.1111/dom.13909
- By:
- Publication type:
- Article
Linagliptin as add‐on to empagliflozin in a fixed‐dose combination in Japanese patients with type 2 diabetes: Glycaemic efficacy and safety profile in a two‐part, randomized, placebo‐controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 1, p. 136, doi. 10.1111/dom.13496
- By:
- Publication type:
- Article
Empagliflozin as add‐on to linagliptin in a fixed‐dose combination in Japanese patients with type 2 diabetes: Glycaemic efficacy and safety profile in a 52‐week, randomized, placebo‐controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 9, p. 2200, doi. 10.1111/dom.13352
- By:
- Publication type:
- Article
Empagliflozin as adjunct to insulin in Japanese participants with type 1 diabetes: Results of a 4‐week, double‐blind, randomized, placebo‐controlled phase 2 trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 9, p. 2190, doi. 10.1111/dom.13351
- By:
- Publication type:
- Article
Effect of hydrochlorothiazide in addition to telmisartan/amlodipine combination for treating hypertensive patients uncontrolled with telmisartan/amlodipine: a randomized, double-blind study.
- Published in:
- Hypertension Research, 2017, v. 40, n. 3, p. 251, doi. 10.1038/hr.2016.124
- By:
- Publication type:
- Article
The efficacy and long-term safety of a triple combination of 80 mg telmisartan, 5 mg amlodipine and 12.5 mg hydrochlorothiazide in Japanese patients with essential hypertension: a randomized, double-blind study with open-label extension.
- Published in:
- Hypertension Research, 2017, v. 40, n. 1, p. 51, doi. 10.1038/hr.2016.100
- By:
- Publication type:
- Article
Safety and Efficacy of Empagliflozin as Add-On Therapy to GLP-1 Receptor Agonist (Liraglutide) in Japanese Patients with Type 2 Diabetes Mellitus: A Randomised, Double-Blind, Parallel-Group Phase 4 Study.
- Published in:
- Diabetes Therapy, 2019, v. 10, n. 3, p. 951, doi. 10.1007/s13300-019-0604-8
- By:
- Publication type:
- Article